Biologics Manufacturing Asia 2024
20th -
21th
March 2024 | 
Marina Bay Sands Expo & Convention Centre, Singapore

Map The Future of Asia's Bioprocessing Sector

20th -
21th
March 2024 | 
Marina Bay Sands Expo & Convention Centre, Singapore
📅 Add to Google Calendar
0 +
Attendees
0 +
Organizations
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies

The 11th Annual Biologics Manufacturing Asia 2024 is Asia’s bioprocessing-focused, knowledge-sharing conference that provides regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest manufacturing technologies and know-how.

We have an agenda built around success stories from Asia’s biopharmas as well as the technical expertise from International Biopharmas and BIG Pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, facility design, and scale-up strategy, fill & finish innovation to streamline the operations amongst other crucial themes.

The BMA 2024 is co-located with 8th Annual Biologistics World Asia 2024, 2nd Clinical Trial Festival Asia 2024 and Asia-Pacific Bioprocessing Excellence Awards Gala Dinner 2024.

Biologics Manufacturing Asia 2024

Explore the most comprehensive upstream processing from early cell isolation and cultivation, cell line engineering, media development, raw materials considerations and more for enhancing and optimizing cell culture return and production rate with cost-reduction strategy. Know-how on the latest development of upstream processing technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically feasible.

Immerse into the most focused biologics downstream processing with the ultimate goal of meeting quality and purity requirements of biologics drug products. Multiple purification approaches, concentration, product recovery, cost reduction and optimizing the integration of continuous manufacturing and utilization of single use disposable systems to optimize biologics manufacturing process production rate will be discussed.

Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.

Understand the challenges and the trends of biomanufacturing facility design in detail and find out the best practices of formulation and bulk technology transfer for optimizing output while maintaining quality and activity of products. Emphasis on scaling up processes without compromising product quality while discussing the latest technology and solution to scale up for maximum output.

Identify the most imminent trends on the emerging technologies and applications with the potential to enhance and fasten the biologics manufacturing process. Applications such as PAT tools, novel technologies in single-use technologies and continuous processing, as well as automation and bioprocessing 4.0 to fasten the biologics manufacturing process will be discussed.

THANK YOU TO OUR SPONSORS









Biologics Manufacturing Asia 2024

Advisory

Amish_Patel-250x250

Amish A. Patel

SVP Technical Operations

Calidi Biotherapeutics
Bakulesh-Khama_photo_profile-3

Bakulesh Khamar

Executive Director,

Cadila Pharmaceuticals,
India
Jean-Francois-Dierick_photo_profile

Jean-François Dierick

Global Subject Matter Expert Analytical Validation & Lifecycle, GSK, Belgium

Wei-Kuang-Chi_photo_profile-1

Wei-Kuang Chi

Distinguished Consultant, Development Center for Biotechnology

Taiwan

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Akira-Kurabayashi_photo_profile-3

Akira Kurabayashi

Head of Digital & Engineering Dept., Chugai Pharma Manufacturing Co., Ltd., Japan

Alois-Jungbauer_photo_profile

Alois Jungbauer

Head of Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Austria

Austria
Bao-Cai_photo_profile

Bao Cai

VP of Biomanufacturing

Bio-Thera Solutions, Ltd,
China
Chester-Drum_photo_profile-3

Chester Drum

MD, PhD, Assistant Professor National University of Singapore, National University Hospital, Singapore

Gary-Khoo_photo_profile

Gary Khoo

VP of Chemistry, Manufacturing & Controls (CMC), Hummingbird Bioscience, Singapore

Jong-Hyuk-Lim_photo_profile

Jong Hyuk Lim

Manager, P1DSS, SME of Cleaning/Disinfection for DS/DP Manufacturing Facility, Celltrion, Korea

Judy-Chou_photo_profile-3

Judy Chou

President and Chief Executive Officer, AltruBio, Inc., USA

Kai-Yin-Po_photo_profile

Kai Yin Po

Associate Principal Scientist, Regulatory Affairs - CMC, MSD, Singapore

KwangJun-Yoon_photo_profile

KwangJun Yoon

Managing Director, Bio GMP Department

CHA Biotech
Korea
Leon-Cruz_photo_profile-3

Leon Cruz

Head of Production, Duopharma, Malaysia 

Niki-Wong_photo_profile

Niki Wong – Keynote

Director, Global Technical Operations, CMC, AbbVie, Singapore

Parthasarathy_Biocon

Parthasarathy Sampath Kumar

Head Center of Operational Excellence - Group COE

Biocon
India
Paul_Song

Paul Song

Chief Scientific Officer

GeneQuantum Healthcare
China
Ashutosh Kumar

Prof. Ashutosh Kumar

Professor, Structural Biology, Department of Biosciences and Bioengineering

Indian Institute of Technology Bombay
India
Seat-Yee-Lau_photo_profile-3

Seat Yee Lau

Director Process Development

Amgen Singapore Manufacturing
Singapore
Sunil-Gadekar_photo_profile

Sunil Gadekar

Global Director- Advanced Therapies, Manufacturing Science and Technology

Johnson & Johnson
Singapore
Swapan-K-Jana_photo_profile

Swapan Kumar Jana

Director - R&D and Manufacturing

Serum Institute of India Pvt. Ltd.
India
Wei-Kuang-Chi_photo_profile-1

Wei-Kuang Chi

Distinguished Consultant, Development Center for Biotechnology

Taiwan
Wolfram-Carius_photo_profile

Wolfram Carius – Keynote

Executive Vice President of Cell and Gene Therapy, Pharmaceuticals Division, Bayer Pharmaceuticals, Germany

yen choo

Yen Choo

Associate Professor of Stem Cell Science and Regenerative Medicine

Lee Kong Chian School of Medicine, Nanyang Technological University
Singapore 
YoungMin-Oh_photo_profile

YoungMin Oh

Managing Director, Head of SMART Team

GI Innovation, Inc.
Korea
Youngsun-Kim_photo_profile

Youngsun Kim

Ph.D., Team Leader of MSAT 1

Samsung Biologics
Korea
Yang-Yuan-Sheng_photo_profile

Yuansheng Yang

Senior Principal Scientist, Group Leader, Cell Line Development

A*STAR
Singapore
Zhang-Wei_photo_profile

Zhang Wei

Principal Scientist, Group Leader, Downstream Processing

A*STAR
Singapore

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA/BIG PHARMA/ACADEMIC (ASIA)
Limited Super (By 18th November 2023)
SGD 1,495

Limited Special (By 2nd February 2024)
SGD 1,695 

Early Bird (By 1st March 2024)
SGD 1,895

Standard Price
SGD 2,095
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
BIOPHARMA/BIG PHARMA/ACADEMIC (OUTSIDE OF ASIA)
Limited Super (By 18th November 2023)
SGD 1,995

Limited Special (By 2nd February 2024)
SGD 2,195 

Early Bird (By 1st March 2024)
SGD 2,395

Standard Price
SGD 2,595
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
SOLUTION PROVIDER
Limited Super (By 18th November 2023)
SGD 3,795

Limited Special (By 2nd February 2024)
SGD 3,995 

Early Bird (By 1st March 2024)
SGD 4,095

Standard Price
SGD 4,295
Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

CCO,  
Regional Commercial Director  

Cold Chain Technologies

BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe,  
Director Business Development & Channel Sales  

MasterControl

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

Senior,  
Technical Account Specialist  

West Pharmaceutical Services

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Nick Kotlarski,  
President, VP of BioManufacturing  

Bioworkshops Limited

The conference was a great success and fruitful.

Cai Bao,  
VP of BioManufacturing  

Biocon

Fantastic conference with professional team.

Julio Lin,  
VP  

Blue Blood Biotech

Informative session. Exhibition was well targeted and diverse. Presenters shared latest development

Sankar Dharmaraj,  
Head, GMP Operations  

Hilman Laboratories

It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!

MD Atiqur Rahman,  
Senior Executive Officer, Professional (Sterile)  

Incepta

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

Koh Wei Jet,  
Sanofi  

EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

Chris Lee,  
Site head, Singapore Development and Manufacturing  

WuXi Biologics

The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.

Chandrakant Kathote,  
Site Head & Vice President  

Lupin Ltd

It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.

Dr. Swapan Kumar Jana,  
Director R&D and Manufacturing  

Serum Institute Of India Pvt. Limited

A well organized ambitious meeting. I hope it will continue to develop in the future.

Jean Francois Dierick,  
Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development  

GSK Vaccines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Download Featured Content Form

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit Brochure

Download Form